Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - ProPhase Labs (NASDAQ: PRPH)
Follow
NASDAQ:PRPH
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
director, 10 percent owner, officer: CEO & CHAIRMAN
03/17/2024
Buy
$6.00
400,000
$2.400M
400,000
NASDAQ
PRPH
ProPhase Labs
Latkin Jed
/
director
01/01/2024
Buy
$6.00
500,000
$3.000M
500,000
NASDAQ
PRPH
ProPhase Labs
Hirsch Warren
/
director
03/17/2024
Buy
$6.00
70,000
$420K
70,000
NASDAQ
PRPH
ProPhase Labs
GLECKEL LOUIS MD
/
director
03/17/2024
Buy
$6.00
70,000
$420K
70,000
NASDAQ
PRPH
ProPhase Labs
Barr Jason Michael
/
director
03/17/2024
Buy
$6.00
70,000
$420K
70,000
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
director, 10 percent owner, officer: CEO & CHAIRMAN
03/17/2024
Sell
$6.00
400,000
$2.400M
400,000
NASDAQ
PRPH
ProPhase Labs
Hirsch Warren
/
director
06/16/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ
PRPH
ProPhase Labs
GLECKEL LOUIS MD
/
director
06/16/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ
PRPH
ProPhase Labs
Barr Jason Michael
/
director
06/16/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ
PRPH
ProPhase Labs
Hirsch Warren
/
director
06/19/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ
PRPH
ProPhase Labs
Barr Jason Michael
/
director
06/19/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ
PRPH
ProPhase Labs
GLECKEL LOUIS MD
/
director
06/19/2023
Buy
$7.31
40,000
$292K
40,000
NASDAQ
PRPH
ProPhase Labs
Morse Robert A. Jr.
/
officer: CHIEF FINANCIAL OFFICER
04/04/2023
Buy
$9.00
50,000
$450K
50,000
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
director, 10 percent owner, officer: CEO & CHAIRMAN
04/03/2023
Buy
$9.00
500,000
$4.500M
500,000
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
director, 10 percent owner, officer: CEO & CHAIRMAN
02/01/2023
Buy
$0.60
500,000
$300K
3.85M
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
director, 10 percent owner, officer: CEO & CHAIRMAN
02/01/2023
Sell
$8.18
268,337
$2.195M
3.58M
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
director, 10 percent owner, officer: CEO & CHAIRMAN
02/01/2023
Sell
$0.60
500,000
$300K
0
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
officer: CEO & CHAIRMAN
01/13/2023
Buy
$0.60
600,000
$360K
3.67M
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
officer: CEO & CHAIRMAN
01/13/2023
Sell
$9.36
319,231
$2.988M
3.35M
NASDAQ
PRPH
ProPhase Labs
Morse Robert A. Jr.
/
officer: Controller
01/13/2023
Sell
$12.01
50,000
$601K
0
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
officer: CEO & CHAIRMAN
10/16/2022
Buy
$0.60
600,000
$360K
3.39M
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
officer: CEO & CHAIRMAN
10/16/2022
Sell
$10.41
317,291
$3.303M
3.07M
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
officer: CEO & CHAIRMAN
08/10/2022
Buy
$0.60
600,000
$360K
3.11M
NASDAQ
PRPH
ProPhase Labs
Karkus Ted William
/
officer: CEO & CHAIRMAN
08/10/2022
Sell
$10.84
316,605
$3.432M
2.79M
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.